Synthesis, anti-Toxoplasma gondii and antimicrobial activities of benzaldehyde 4-phenyl-3-thiosemicarbazones and 2-[(phenylmethylene)hydrazono]-4-oxo-3-phenyl-5-thiazolidineacetic acids

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 1, 2008, Pages 446-456

  de Aquino, Thiago M ^a   Liesen, André P ^a   da Silva, Rosa E A ^a   Lima, Vânia T ^a   Carvalho, Cristiane S ^b   de Faria, Antônio R ^a   de Araújo, Janete M ^a   de Lima, José G ^a   Alves, Antonio J ^a   de Melo, Edésio J T ^b   Góes, Alexandre J S ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE DARCY RIBEIRO   (Brazil)

Author keywords

4 Thiazolidinone; Anti Toxoplasma gondii activity; Antimicrobial activity; Thiosemicarbazone

Indexed keywords

2 [(PHENYLMETHYLENE)HYDRAZONO] 4 OXO 3 PHENYL 5 THIAZOLIDINEACETIC ACID; 2 [[(2,4 DICHLOROPHENYL)METHYLENE]HYDRAZONO] 4 OXO 3 PHENYL 5 THIAZOLIDINEACETIC ACID; 2 [[(2,4 DIMETHOXYPHENYL)METHYLENE]HYDRAZONO] 4 OXO 3 PHENYL 5 THIAZOLIDINEACETIC ACID; 2 [[(3 METHOXYPHENYL)METHYLENE]HYDRAZONO] 4 OXO 3 PHENYL 5 THIAZOLIDINEACETIC ACID; 2 [[(4 FLUOROPHENYL)METHYLENE]HYDRAZONO] 4 OXO 3 PHENYL 5 THIAZOLIDINEACETIC ACID; BENZALDEHYDE 4 PHENYL 3 THIOSEMICARBAZONE; CHLORAMPHENICOL; NYSTATIN; RIFAMPICIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CANDIDA; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; IC 50; IN VITRO STUDY; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM LUTEUS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TACHYZOITE; TOXOPLASMA GONDII;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIPROTOZOAL AGENTS; CANDIDA; HUMANS; INHIBITORY CONCENTRATION 50; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; SPECTRUM ANALYSIS; THIAZOLIDINES; THIOSEMICARBAZONES; TOXOPLASMA;

CANDIDA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; TOXOPLASMA GONDII;

EID: 38049088866     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.09.025     Document Type: Article

References (35)

1. Hirst S.L., and Stapley L.A. Parasitol. Today 16 (2000) 1
2. Iwu M.M., Jackson J.E., and Schuster B.G. Parasitol. Today 10 (1994) 65
3. Berman J. Curr. Opin. Infect. Dis. 11 (1998) 707
4. Bhopale G.M. Comp. Immun. Microbiol. Infect. Dis 26 (2003) 213
5. Jackson M.H., and Hutchison W.M. In: Baker J.R., and Muller R. (Eds). The Prevalence and Source of Toxoplasma Infection in the Environment (1989), Academic Press, London 55-105
6. Remington J.S., Mcleod R., and Desmonts G. In: Remington J.S., and Klein J.O. (Eds). Toxoplasmosis (1995), W.B. Saunders & Co., Philadelphia 140-267
7. Montaya J.G., and Remington J.S. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Toxoplasma gondii (2000), Churchill Livingstone, Philadelphia 2858-2881
8. Dannemann B.R., Israelski D.M., Leoung G.S., McGraw T., Mills J., and Remington J.S. AIDS 5 (1991) 1363
9. Wong S.Y., and Remington J.S. AIDS 7 (1993) 299
10. Aspinall T.V., Joynson D.H., Guy E., Hyde J.E., and Sims P.F. J. Infect. Dis. 185 (2002) 1637
11. Subauste C.S., and Remington J.S. Curr. Opin. Immunol. 5 (1993) 532
12. Pena-Rodriguez L.M. Nat. Prod. Rep. 18 (2000) 674
13. Lockwood D. Nat. Méd. 10 (2004) 110
14. Choi C.M., and Lerner E.A. Am. J. Clin. Dermatol. 3 (2002) 91
15. Silva E.S., Pacheco R.S., Gontijo C.M., Carvalho I.R., and Brazil R.P. Rev. Inst. Méd. Trop. São Paulo 2 (2002) 564
16. Arguello C. Av. Perspectiva 14 (1995) 21
17. Fournet A., and Munoz V. Curr. Top. Med. Chem. 2 (2002) 1215
18. Tenório R.P., Carvalho C.S., Pessanha C.S., Lima J.G., Faria A.R., Alves A.J., Melo E.J.T., and Góes A.J.S. Bioorg. Med. Chem. Lett. 15 (2005) 2575
19. Çapan G., Ulusoy N., Ergenç N., and Kiraz M. Monatshefte für Chemie 130 (1999) 1399
20. Vigorita M.G., Ottanà R., Monforte F., Maccari R., Trivato A., Monforte M.T., and Taviano M.F. Bioorg. Med. Chem. Lett. 11 (2001) 2791
21. Rawal R.K., Prabhakar Y.S., Katti S.B., and Clercq E. Bioorg. Med. Chem. 13 (2005) 6771
22. Babaoglu K., Page M.A., Jones V.C., McNeil M.R., Dong C., Naismith J.H., and Lee R.E. Bioorg. Med. Chem. Lett. 13 (2003) 3227
23. Alves A.J., Ramos S.V.V., Silva M.J., Fulcrand P., Artis A.M., and Quero A.M. Rev. Farm. Bioquím. Univ. São Paulo 34 (1998) 77
24. Alves A.J., Leite A.C.L., Santana D.P., Beltrão T.M., and Coelho M.R.D. IL Fármaco 48 (1993) 1167
25. Bharti N., Husain K., Garza M.T.G., Vega D.E.C., Garza J.C., Cardenas B.D.M., and Naqvi F. Bioorg. Med. Chem. Lett. 12 (2002) 3475
26. Ulusoy N., Kiraz M., and Küçükbasmaci O. Monatsh. Chem. 133 (2002) 1305
27. El-Gendy Z., Abdel-Rahman R.M., and Fawzy M.M. J. Indian Chem. Soc. 67 (1990) 927
28. El-Khawass S.M., Khalil M.A., and Chaaban I. IL Fármaco 44 (1989) 415
29. Balasubramaniyan V., Balasubramaniyan P., and Wani M.J. Indian J. Chem. B 29 (1990) 1092
30. Ergenç N., Çapan G., Günay N.S., Özkirimli S., Güngör M., Özbey S., and Kendi E. Arch. Pharm. Med. Chem. 332 (1999) 343
31. Melo E.J.T., Mayerhoffer R.O., and Souza W. FEMS Microbiol. Lett. 185 (2000) 79
32. Melo E.J.T., and Beiral H.J. Braz. J. Med. Biol. Res. 36 (2003) 65
33. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, 5th ed. Approved Standard. NCCLS publication M2-A5. Villanova, PA, 1993.
34. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 3th ed. Approved Standard. NCCLS publication M7-A3. Villanova, PA, 1993.
35. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Proposed Standard. NCCLS Document M27-P. Villanova, PA, 1992.